James N. Topper - 29 Dec 2023 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role: Director
Signature: /s/ James N. Topper
Issuer symbol: NAMS
Transactions as of: 29 Dec 2023
Net transactions value: $0
Form type: 3
Filing time: 29 Dec 2023, 16:30:23 UTC
Previous filing: 13 Dec 2023
Next filing: 04 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NAMS	Ordinary Shares						3,801,000	29 Dec 2023	Frazier Lifesciences Sponsor LLC	F1
holding	NAMS	Ordinary Shares						3,000,000	29 Dec 2023	Frazier Life Sciences X, L.P.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NAMS	Warrant (right to buy)							29 Dec 2023	Ordinary Shares	167,000	$11.50	Frazier Lifesciences Sponsor LLC	F1
holding	NAMS	Warrant (right to buy)							29 Dec 2023	Ordinary Shares	333,333	$11.50	Frazier Life Sciences X, L.P.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are held directly by Frazier Lifesciences Sponsor LLC ("Sponsor"). The sole member of Sponsor is Frazier Life Sciences X, L.P. ("FLS X"). FHMLS X, L.P. is the general partner of FLS X and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper is one of two managing members of FHMLS X, L.L.C. Dr. Topper disclaims beneficial ownership of the securities held by FLS Sponsor except for his pecuniary interest therein, if any.
F2	The securities are held directly by FLS X. FHMLS X, L.P. is the general partner of FLS X and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper is one of two managing members of FHMLS X, L.L.C.. Dr. Topper disclaims beneficial ownership of the securities held by FLS X except for his pecuniary interest therein, if any.

Content

The securities are held directly by Frazier Lifesciences Sponsor LLC ("Sponsor"). The sole member of Sponsor is Frazier Life Sciences X, L.P. ("FLS X"). FHMLS X, L.P. is the general partner of FLS X and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper is one of two managing members of FHMLS X, L.L.C. Dr. Topper disclaims beneficial ownership of the securities held by FLS Sponsor except for his pecuniary interest therein, if any.

The securities are held directly by FLS X. FHMLS X, L.P. is the general partner of FLS X and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. James N. Topper is one of two managing members of FHMLS X, L.L.C.. Dr. Topper disclaims beneficial ownership of the securities held by FLS X except for his pecuniary interest therein, if any.